Amplifying “eat me signal” by immunogenic cell death for potentiating cancer immunotherapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Amplifying “eat me signal” by immunogenic cell death for potentiating cancer immunotherapy
Authors
Keywords
-
Journal
IMMUNOLOGICAL REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-08-08
DOI
10.1111/imr.13251
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Catalytically Active Metal–Organic Frameworks Elicit Robust Immune Response to Combination Chemodynamic and Checkpoint Blockade Immunotherapy
- (2023) Xue Wang et al. ACS Applied Materials & Interfaces
- Immunoinducible Carbon Dot-Incorporated Hydrogels as a Photothermal-Derived Antigen Depot to Trigger a Robust Antitumor Immune Response
- (2023) Suwan Liu et al. ACS Applied Materials & Interfaces
- Conjugation of Macrophage-Mimetic Microalgae and Liposome for Antitumor Sonodynamic Immunotherapy via Hypoxia Alleviation and Autophagy Inhibition
- (2023) Cheng Gao et al. ACS Nano
- Carrier-Free Immunotherapeutic Nano-Booster with Dual Synergistic Effects Based on Glutaminase Inhibition Combined with Photodynamic Therapy
- (2023) Ziyi Mai et al. ACS Nano
- Gold nanobipyramid@copper sulfide nanotheranostics for image-guided NIR-II photo/chemodynamic cancer therapy with enhanced immune response
- (2023) Yiyu Chen et al. Acta Biomaterialia
- Oxygen‐Deficient Molybdenum Oxide Nanosensitizers for Ultrasound‐Enhanced Cancer Metalloimmunotherapy
- (2023) Yuanjie Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Mitochondria-Targeting and Multiresponsive Nanoplatform Based on AIEgens for Synergistic Chemo-Photodynamic Therapy and Enhanced Immunotherapy
- (2023) Qiyi Feng et al. Biomacromolecules
- Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy
- (2023) Gaopeng Li et al. CANCER CELL
- Yes-Associated Protein 1 Inhibition Induces Immunogenic Cell Death and Synergizes With Radiation and PD-1 Blockade
- (2023) Yuan Zhuang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Novel Tri‐Functional Liposome Re‐Educates “Cold Tumor” and Abrogates Tumor Growth by Synergizing Autophagy Inhibition and PD‐L1 Blockade
- (2023) Fei Zhou et al. Advanced Healthcare Materials
- Ultrasound targeted microbubble destruction-triggered nitric oxide release via nanoscale ultrasound contrast agent for sensitizing chemoimmunotherapy
- (2023) Yading Zhao et al. JOURNAL OF NANOBIOTECHNOLOGY
- Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control
- (2023) Maria E Rodriguez-Ruiz et al. Journal for ImmunoTherapy of Cancer
- Multifunctional Nano‐Biomaterials for Cancer Therapy via Inducing Enhanced Immunogenic Cell Death
- (2023) Qian Chen et al. Small Methods
- A Three‐in‐One Nanoscale Coordination Polymer for Potent Chemo‐Immunotherapy
- (2023) Jing Liu et al. Small Methods
- Interrelation between Programmed Cell Death and Immunogenic Cell Death: Take Antitumor Nanodrug as an Example
- (2023) Qi Meng et al. Small Methods
- NIR-II light evokes DNA cross-linking for chemotherapy and immunogenic cell death
- (2023) Yun Huang et al. Acta Biomaterialia
- Immunogenic Cell Death Inducing Metal Complexes for Cancer Therapy
- (2023) Lingpu Zhang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival
- (2023) Giuseppina Catania et al. BIOMATERIALS
- Engineering nanoparticles boost TNBC therapy by CD24 blockade and mitochondrial dynamics regulation
- (2023) Ming Zhao et al. JOURNAL OF CONTROLLED RELEASE
- Co-delivery of gemcitabine and paclitaxel plus NanoCpG empowers chemoimmunotherapy of postoperative “cold” triple-negative breast cancer
- (2023) Beibei Guo et al. Bioactive Materials
- Glutamine Metabolism-Regulated Nanoparticles to Enhance Chemoimmunotherapy by Increasing Antigen Presentation Efficiency
- (2022) Bin Du et al. ACS Applied Materials & Interfaces
- Chromatin remodeling induced by ARID1A loss in lung cancer promotes glycolysis and confers JQ1 vulnerability
- (2022) Xiaoyu Liu et al. CANCER RESEARCH
- Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial
- (2022) Jonathan D Schoenfeld et al. LANCET ONCOLOGY
- Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death
- (2022) Yujeong Moon et al. Theranostics
- A light-driven dual-nanotransformer with deep tumor penetration for efficient chemo-immunotherapy
- (2022) Jiahui Peng et al. Theranostics
- Design of Light‐Activated Nanoplatform through Boosting “Eat Me” Signals for Improved CD47‐Blocking Immunotherapy
- (2022) Yan Lu et al. Advanced Healthcare Materials
- Extracellular matrix-degrading STING nanoagonists for mild NIR-II photothermal-augmented chemodynamic-immunotherapy
- (2022) Meixiao Zhan et al. JOURNAL OF NANOBIOTECHNOLOGY
- Dynamic Adjust of Non‐Radiative and Radiative Attenuation of AIE Molecules Reinforces NIR‐II Imaging Mediated Photothermal Therapy and Immunotherapy
- (2022) Zhenjie Wang et al. Advanced Science
- A carrier-free photodynamic nanodrug to enable regulation of dendritic cells for boosting cancer immunotherapy
- (2022) Xiaohan Qin et al. Acta Biomaterialia
- Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer
- (2022) Heshi Liu et al. Acta Biomaterialia
- An Injectable Nanocomposite Hydrogel Improves Tumor Penetration and Cancer Treatment Efficacy
- (2022) Feng Qin Luo et al. Acta Biomaterialia
- Restoration of the Immunogenicity of Tumor Cells for Enhanced Cancer Therapy via Nanoparticle‐Mediated Copper Chaperone Inhibition
- (2022) Feixiang Ding et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Chemiluminescence resonance energy transfer-based immunostimulatory nanoparticles for sonoimmunotherapy
- (2022) Jueun Jeon et al. BIOMATERIALS
- Mitochondrial targeted AIEgen phototheranostics for bypassing immune barrier via encumbering mitochondria functions
- (2022) Pai Liu et al. BIOMATERIALS
- FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer
- (2022) Violaine Randrian et al. DIGESTIVE AND LIVER DISEASE
- Sonosensitizer nanoplatform-mediated sonodynamic therapy induced immunogenic cell death and tumor immune microenvironment variation
- (2022) Jing Zheng et al. DRUG DELIVERY
- Photothermal MnO2 nanoparticles boost chemo-photothermal therapy-induced immunogenic cell death in tumor immunotherapy
- (2022) Zhenzhen Chen et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A bio-responsive, cargo-catchable gel for postsurgical tumor treatment via ICD-based immunotherapy
- (2022) Qian Chen et al. JOURNAL OF CONTROLLED RELEASE
- Blocking CD47 promotes antitumour immunity through CD103+ dendritic cell–NK cell axis in murine hepatocellular carcinoma model
- (2022) Shuai Wang et al. JOURNAL OF HEPATOLOGY
- Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial
- (2022) Carlotta Antoniotti et al. LANCET ONCOLOGY
- NIR-II Responsive Molybdenum Dioxide Nanosystem Manipulating Cellular Immunogenicity for Enhanced Tumor Photoimmunotherapy
- (2022) Peilin Lan et al. NANO LETTERS
- A Three‐In‐One Assembled Nanoparticle Containing Peptide–Radio‐Sensitizer Conjugate and TLR7/8 Agonist Can Initiate the Cancer‐Immunity Cycle to Trigger Antitumor Immune Response
- (2022) Xueqin Zhu et al. Small
- An Intelligent Nanovehicle Armed with Multifunctional Navigation for Precise Delivery of Toll‐Like Receptor 7/8 Agonist and Immunogenic Cell Death Amplifiers to Eliminate Solid Tumors and Trigger Durable Antitumor Immunity
- (2022) Yanyun Hao et al. Advanced Healthcare Materials
- Targeting the Negative Feedback of Adenosine‐A2AR Metabolic Pathway by a Tailored Nanoinhibitor for Photothermal Immunotherapy
- (2022) Yiqiong Liu et al. Advanced Science
- Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma
- (2022) Zhongren Xu et al. Redox Biology
- A ROS-responsive synergistic delivery system for combined immunotherapy and chemotherapy
- (2022) Doudou Hu et al. Materials Today Bio
- Self-Assembled Immunostimulatory Tetrahedral Framework Nucleic Acid Vehicles for Tumor Chemo-immunotherapy
- (2022) Mengting Liu et al. ACS Applied Materials & Interfaces
- Blockage of the IDO1 pathway by charge-switchable nanoparticles amplifies immunogenic cell death for enhanced cancer immunotherapy
- (2022) Menghao Shi et al. Acta Biomaterialia
- Two‐Dimensional Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy
- (2022) Taokun Luo et al. ADVANCED MATERIALS
- A Self‐Reporting Fluorescent Salicylaldehyde–Chlorambucil Conjugate as a Type‐II ICD Inducer for Cancer Vaccines
- (2022) Minjie Zhang et al. ADVANCED MATERIALS
- Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression
- (2022) Minhee Kim et al. JOURNAL OF CONTROLLED RELEASE
- Combination of oxaliplatin and POM-1 by nanoliposomes to reprogram the tumor immune microenvironment
- (2022) Xianglei Fu et al. JOURNAL OF CONTROLLED RELEASE
- Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death
- (2022) Xuhui Bao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression
- (2022) Chengqiong Mao et al. Science Translational Medicine
- Rationally Designed Heptamethine Cyanine Photosensitizers that Amplify Tumor‐Specific Endoplasmic Reticulum Stress and Boost Antitumor Immunity
- (2022) Xie Huang et al. Small
- Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy
- (2022) Haiqin Song et al. JOURNAL OF NANOBIOTECHNOLOGY
- Aggregation-induced emission photosensitizer-based photodynamic therapy in cancer: from chemical to clinical
- (2022) Zijuan Meng et al. JOURNAL OF NANOBIOTECHNOLOGY
- Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment
- (2022) Jun Gu et al. JOURNAL OF NANOBIOTECHNOLOGY
- PD-1 Inhibitor Combined With Radiotherapy and GM-CSF (PRaG) in Patients With Metastatic Solid Tumors: An Open-Label Phase II Study
- (2022) Yuehong Kong et al. Frontiers in Immunology
- Hierarchical Microparticles Delivering Oxaliplatin and NLG919 Nanoprodrugs for Local Chemo-immunotherapy
- (2022) Qingfei Zhang et al. ACS Applied Materials & Interfaces
- Degradable Multifunctional Porphyrin-Based Porous Organic Polymer Nanosonosensitizer for Tumor-Specific Sonodynamic, Chemo- and Immunotherapy
- (2022) Meiting Li et al. ACS Applied Materials & Interfaces
- 2D Copper(II) Metalated Metal–Organic Framework Nanocomplexes for Dual-enhanced Photodynamic Therapy and Amplified Antitumor Immunity
- (2022) Zixuan Chen et al. ACS Applied Materials & Interfaces
- Tumor-Homing and Immune-Reprogramming Cellular Nanovesicles for Photoacoustic Imaging-Guided Phototriggered Precise Chemoimmunotherapy
- (2022) Zhijin Fan et al. ACS Nano
- Synergistic Reinforcing of Immunogenic Cell Death and Transforming Tumor‐Associated Macrophages Via a Multifunctional Cascade Bioreactor for Optimizing Cancer Immunotherapy
- (2022) Cong Huang et al. ADVANCED MATERIALS
- Aggregation‐Induced‐Emission Photosensitizer‐Loaded Nano‐superartificial Dendritic Cells with Directly Presenting Tumor Antigens and Reversed Immunosuppression for Photodynamically Boosted Immunotherapy
- (2022) Zhihong Sun et al. ADVANCED MATERIALS
- Phosphorous Dendron Micelles as a Nanomedicine Platform for Cooperative Tumor Chemoimmunotherapy via Synergistic Modulation of Immune Cells
- (2022) Mengsi Zhan et al. ADVANCED MATERIALS
- Pembrolizumab versus cetuximab, concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase 2 trial
- (2022) Y. Tao et al. ANNALS OF ONCOLOGY
- Cinnamaldehyde-based poly(thioacetal): A ROS-awakened self-amplifying degradable polymer for enhanced cancer immunotherapy
- (2022) Yalan Tu et al. BIOMATERIALS
- Evoking tumor associated macrophages by mitochondria-targeted magnetothermal immunogenic cell death for cancer immunotherapy
- (2022) Han Jiang et al. BIOMATERIALS
- Dying in self-defence: a comparative overview of immunogenic cell death signalling in animals and plants
- (2022) Takaki Maekawa et al. CELL DEATH AND DIFFERENTIATION
- Camptothesome elicits immunogenic cell death to boost colorectal cancer immune checkpoint blockade
- (2022) Zhiren Wang et al. JOURNAL OF CONTROLLED RELEASE
- Tumor microenvironment antigens
- (2022) Mads Hald Andersen Seminars in Immunopathology
- Ischemia and reperfusion injury combined with cisplatin induces immunogenic cell death in lung cancer cells
- (2022) Shuai Zhang et al. Cell Death & Disease
- Enhanced radiation-induced immunogenic cell death activates chimeric antigen receptor T cells by targeting CD39 against glioblastoma
- (2022) Ting Sun et al. Cell Death & Disease
- Supramolecular Polypeptide Self‐Assembly Mediated in Situ Elicitation of Robust Innate and Adaptive Immune Responses Boosts Immunogenic Photothermal Therapy Toward “Cold” Tumor
- (2022) Kai Shi et al. Advanced Healthcare Materials
- Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19
- (2022) Ziad Bakouny et al. JAMA Oncology
- Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial
- (2022) Julia Katharina Schwarze et al. Journal for ImmunoTherapy of Cancer
- Nanodroplet-enhanced sonodynamic therapy potentiates immune checkpoint blockade for systemic suppression of triple-negative breast cancer
- (2022) Wenxin Wu et al. Acta Biomaterialia
- Multifunctional biomimetic nanoplatform based on photodynamic therapy and DNA repair intervention for the synergistic treatment of breast cancer
- (2022) Hang Wu et al. Acta Biomaterialia
- BSA‐AIE Nanoparticles with Boosted ROS Generation for Immunogenic Cell Death Immunotherapy of Multiple Myeloma
- (2022) Zhaoyun Liu et al. ADVANCED MATERIALS
- A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer
- (2022) Defan Yao et al. BIOMATERIALS
- Epigenetic reprogramming of carrier free photodynamic modulator to activate tumor immunotherapy by EZH2 inhibition
- (2022) Linping Zhao et al. BIOMATERIALS
- 5-ALA mediated photodynamic therapy with combined treatment improves anti-tumor efficacy of immunotherapy through boosting immunogenic cell death
- (2022) Zhuoran Sun et al. CANCER LETTERS
- Necroptosis-dependent Immunogenicity of Cisplatin: Implications for Enhancing the Radiation-induced Abscopal Effect
- (2022) Ren Luo et al. CLINICAL CANCER RESEARCH
- Multifunctional Nanoparticles-Mediated PTT/PDT Synergistic Immune Activation and Antitumor Activity Combined with Anti-PD-L1 Immunotherapy for Breast Cancer Treatment
- (2022) Cunqing Kong et al. International Journal of Nanomedicine
- A macrophage membrane-coated mesoporous silica nanoplatform inhibiting adenosine A2AR via in situ oxygen supply for immunotherapy
- (2022) Xudong Wen et al. JOURNAL OF CONTROLLED RELEASE
- A Biomimetic Metal-Organic Framework Nanosystem Modulates Immunosuppressive Tumor Microenvironment Metabolism to Amplify Immunotherapy
- (2022) Huaiji Wang et al. JOURNAL OF CONTROLLED RELEASE
- 3′-epi-12β-hydroxyfroside-mediated autophagy degradation of RIPK1/RIPK3 necrosomes leads to anergy of immunogenic cell death in triple-negative breast cancer cells
- (2022) Feng-Ying Huang et al. PHARMACOLOGICAL RESEARCH
- Induction of immunogenic cell death by novel platinum-based anticancer agents
- (2022) Xingyu Chang et al. PHARMACOLOGICAL RESEARCH
- Cascade Immune Activation of Self‐Delivery Biomedicine for Photodynamic Immunotherapy Against Metastatic Tumor
- (2022) Rong‐Rong Zheng et al. Small
- Rhythm Mild‐Temperature Photothermal Therapy Enhancing Immunogenic Cell Death Response in Oral Squamous Cell Carcinoma
- (2022) Jianchuan Ran et al. Advanced Healthcare Materials
- Tumor Cell‐Responsive Photodynamic Immunoagent for Immunogenicity‐Enhanced Orthotopic and Remote Tumor Therapy
- (2022) Yingchao Chen et al. Advanced Healthcare Materials
- Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy
- (2022) Lipeng Zhu et al. JOURNAL OF NANOBIOTECHNOLOGY
- Polymeric nanoparticle-based nanovaccines for cancer immunotherapy
- (2022) Yongxin Zhang et al. Materials Horizons
- Emerging Sonodynamic Therapy‐Based Nanomedicines for Cancer Immunotherapy
- (2022) Yunrong Yang et al. Advanced Science
- Ferritin Nanocaged Doxorubicin Potentiates Chemo‐Immunotherapy against Hepatocellular Carcinoma via Immunogenic Cell Death
- (2022) Yang Chen et al. Small Methods
- Biomimetic manganese-based theranostic nanoplatform for cancer multimodal imaging and twofold immunotherapy
- (2022) Yuyue Zhao et al. Bioactive Materials
- Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti-cancer evaluation of peritumoral hydrogel injection combined with PD-L1 antibody
- (2022) Hao Wu et al. Biomaterials Research
- Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy
- (2022) Biao-Qi Chen et al. Bioactive Materials
- CD47KO/CRT dual-bioengineered cell membrane-coated nanovaccine combined with anti-PD-L1 antibody for boosting tumor immunotherapy
- (2022) Shengyang Liu et al. Bioactive Materials
- A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody
- (2022) Zhilin Li et al. Bioactive Materials
- Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancer
- (2021) Bianca Oresta et al. Science Translational Medicine
- Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress
- (2021) Zhusheng Huang et al. Nature Communications
- Imaging calreticulin for early detection of immunogenic cell death during anticancer treatment
- (2021) Dong-Yeon Kim et al. JOURNAL OF NUCLEAR MEDICINE
- Exploiting Tumor Neoantigens to Target Cancer Evolution: Current Challenges and Promising Therapeutic Approaches
- (2021) Ravi G. Gupta et al. Cancer Discovery
- Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy
- (2021) Ziyuan Huang et al. ACS Applied Materials & Interfaces
- Calcium Phosphate‐Reinforced Metal‐Organic Frameworks Regulate Adenosine‐Mediated Immunosuppression
- (2021) Ling Liang et al. ADVANCED MATERIALS
- Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial
- (2021) David Cibula et al. GYNECOLOGIC ONCOLOGY
- Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial
- (2021) David A. Bernal-Estévez et al. Frontiers in Immunology
- A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer
- (2021) Dandan Sun et al. Acta Pharmaceutica Sinica B
- Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer
- (2021) Xinyun Qiu et al. JOURNAL OF CONTROLLED RELEASE
- Paclitaxel derivative-based liposomal nanoplatform for potentiated chemo-immunotherapy
- (2021) Yingli Wang et al. JOURNAL OF CONTROLLED RELEASE
- Fibroblast Activation Protein‐α Responsive Peptide Assembling Prodrug Nanoparticles for Remodeling the Immunosuppressive Microenvironment and Boosting Cancer Immunotherapy
- (2021) Mengqi Sun et al. Small
- Stimuli-responsive nano vehicle enhances cancer immunotherapy by coordinating mitochondria-targeted immunogenic cell death and PD-L1 blockade
- (2021) Qiuyi Li et al. Acta Pharmaceutica Sinica B
- Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy
- (2021) Xianbin Ma et al. Acta Pharmaceutica Sinica B
- Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy
- (2021) Jiayi Ye et al. Acta Pharmaceutica Sinica B
- Inhibition of Immunosuppressive Tumors by Polymer‐Assisted Inductions of Immunogenic Cell Death and Multivalent PD‐L1 Crosslinking
- (2020) Lian Li et al. ADVANCED FUNCTIONAL MATERIALS
- Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastases
- (2020) Vegar Johansen Dagenborg et al. CANCER BIOLOGY & THERAPY
- Reshaping Tumor Immune Microenvironment through Acidity-Responsive Nanoparticles Featured with CRISPR/Cas9-Mediated Programmed Death-Ligand 1 Attenuation and Chemotherapeutics-Induced Immunogenic Cell Death
- (2020) Kun Tu et al. ACS Applied Materials & Interfaces
- AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer
- (2020) Carlotta Antoniotti et al. BMC CANCER
- The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
- (2020) Yuanyuan Zhang et al. Cellular & Molecular Immunology
- ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer
- (2020) J. A. Kyte et al. Journal of Translational Medicine
- ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer
- (2020) J. A. Kyte et al. Journal of Translational Medicine
- Beyond CAR T cells: Engineered Vγ9Vδ2 T cells to fight solid tumors
- (2020) Chirine Rafia et al. IMMUNOLOGICAL REVIEWS
- The distinct MHC‐unrestricted immunobiology of innate‐like and adaptive‐like human γδ T cell subsets—Nature's CAR‐T cells
- (2020) Carrie R. Willcox et al. IMMUNOLOGICAL REVIEWS
- Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma
- (2020) Sean McBride et al. JOURNAL OF CLINICAL ONCOLOGY
- Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy
- (2020) Hanzhang Zhu et al. CELLULAR ONCOLOGY
- Corn-like Au/Ag nanorod-mediated NIR-II photothermal/photodynamic therapy potentiates immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment
- (2020) Liangjie Jin et al. BIOMATERIALS
- Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death
- (2020) K. Hayashi et al. Nature Communications
- Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade
- (2019) Fangyuan Zhou et al. ADVANCED MATERIALS
- CAR T cells for brain tumors: Lessons learned and road ahead
- (2019) David Akhavan et al. IMMUNOLOGICAL REVIEWS
- HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells
- (2019) Wenwen Chai et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
- (2019) Amira A. Barkal et al. NATURE
- Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death
- (2019) Wei Li et al. Nature Communications
- Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
- (2019) Georgina V Long et al. LANCET ONCOLOGY
- Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages
- (2019) Emeric Limagne et al. Cancer Immunology Research
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- (2018) Frederick F. Lang et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors
- (2018) Asha Nayak-Kapoor et al. Journal for ImmunoTherapy of Cancer
- A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)–only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer
- (2017) Rebecca Kristeleit et al. GYNECOLOGIC ONCOLOGY
- Immune recognition of irradiated cancer cells
- (2017) Erik Wennerberg et al. IMMUNOLOGICAL REVIEWS
- Immunogenic cell death
- (2015) Abhishek D. Garg et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death
- (2013) Abhishek D. Garg et al. Autophagy
- Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists
- (2013) T Yamazaki et al. CELL DEATH AND DIFFERENTIATION
- Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response
- (2011) J. Fucikova et al. CANCER RESEARCH
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
- Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
- (2009) Theocharis Panaretakis et al. EMBO JOURNAL
- Immunogenic cancer cell death: a key-lock paradigm
- (2008) Antoine Tesniere et al. CURRENT OPINION IN IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started